15 completed, 3 unknown, 2 recruiting. 5 Not applicable, 4 Phase 2, 3 Phase 4, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 3, Recruiting 1, Unknown 1 |
| Phase 2 | 4 | Completed 4 |
| Phase 4 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Acute Myeloblastic Leukemia: new trials by email Literature Review of Acute Myeloblastic Leukemia trials Research Report on Acute Myeloblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients Epigenetic markers - Acute Myeloblastic Leukemia | Not applicable | Recruiting | Groupe Hospitalier de la Region de Mulhouse et Sud Alsace | 30 | 2026-01-13 | 2026-02-04 |
| Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies Ceftazidime, Ciprofloxacin - Neutropenic Fever, Acute Lymphoblastic Leukemia | Phase 4 | Recruiting | Gadjah Mada University | 120 | 2025-06-01 | 2025-08-22 |
| Impact of Optical Genome Mapping in Acute Myeloblastic Leukemia Acute Myeloblastic Leukemia | Completed | University Hospital, Bordeaux | 120 | 2023-01-27 | 2025-07-30 | |
| Effects of Music Therapy in Controlling Symptoms in Patients With AML and Undergoing HSCT Passive music therapy - Acute Myeloblastic Leukemia, Hematopoietic Stem Cell Transplantation | Not applicable | Completed | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 71 | 2021-02-01 | 2023-01-25 |
| Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19 Acute Myeloblastic Leukemia, Acute Lymphoblastic Leukemia | Completed | French Innovative Leukemia Organisation | 79 | 2020-09-11 | 2022-07-27 | |
| Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia Yttrium-90 labelled monoclonal antibody against CD66 - Acute Myeloblastic Leukemia, Acute Lymphoblastic Leukemia | Phase 1 | Completed | Great Ormond Street Hospital for Children NHS Foundation Trust | 9 | 2016-05-01 | 2021-06-25 |
| Observational Study of Patients Older Than 60 Years With Acute Myeloblastic Leukemia Acute Myeloblastic Leukemia, Aged Higher Than 60 Years Old | Unknown | Assistance Publique - Hôpitaux de Paris | 1000 | 2012-11-01 | 2017-11-20 | |
| Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia fludarabine, Idarubicin, cytarabine - Acute Myeloblastic Leukemia | Phase 1 / Phase 2 | Completed | PETHEMA Foundation | 55 | 2012-07-01 | 2017-04-25 |
| Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia sodium chloride solution 0.9%, temsirolimus - Acute Myeloblastic Leukemia | Phase 2 | Completed | Goethe University | 33 | 2012-05-01 | 2023-05-24 |
| Transplant T CD4+ CCR7+ In Hematopoietic Stem Cells Allograft blood - Acute Myeloblastic Leukemia | Not applicable | Completed | University Hospital, Lille | 20 | 2012-03-20 | 2017-09-12 |
| Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen Clofarabine/Busulfan x 4, Peripheral blood stem cell transplant - Acute Myeloblastic Leukemia | Phase 2 | Completed | University of Michigan Rogel Cancer Center | 75 | 2011-11-01 | 2017-06-02 |
| RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AML Acute Lymphoblastic Leukemia., Acute Myeloblastic Leukemia | Unknown | National Institute of Cancerología | 50 | 2010-12-01 | 2013-11-15 | |
| PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years IDARUBICINE, ARA-C - Acute Myeloblastic Leukemia | Not applicable | Unknown | PETHEMA Foundation | 200 | 2010-12-01 | 2021-03-23 |
| LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML) gemtuzumab - Acute Myeloblastic Leukemia | Phase 4 | Completed | PETHEMA Foundation | 200 | 2007-10-01 | 2013-07-31 |
| Natural Killer Index From Hematopoietic Stem Cell Graft Blood test - Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia | Not applicable | Completed | Nantes University Hospital | 92 | 2007-04-01 | 2026-09-14 |
| Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia | Completed | Sheba Medical Center | 35 | 2005-10-01 | 2007-11-02 | |
| Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant Alentuzumab, Globulina antilinfocitaria - Acute Myeloblastic Leukemia, Lymphoblastic Leukemia | Phase 2 / Phase 3 | Completed | Gruppo Italiano Trapianto di Midollo Osseo | 121 | 2005-03-01 | 2023-03-10 |
| Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients Questionnaire - Myelodysplastic Syndrome, Acute Myeloblastic Leukemia | Completed | M.D. Anderson Cancer Center | 30 | 2004-05-01 | 2012-08-01 | |
| Treatment of Acute Myeloblastic Leukemia in Younger Patients chemotherapy - Acute Myeloblastic Leukemia | Completed | PETHEMA Foundation | 600 | 1999-01-01 | 2010-03-15 | |
| SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia Fludarabine, Cytarabine, G-CSF - Myelodysplastic Syndrome, Acute Myeloblastic Leukemia | Phase 4 | Completed | PETHEMA Foundation | 200 | 1998-07-01 | 2008-11-19 |
Leukemia, Myeloid, Acute (20) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (7) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Myelodysplastic Syndromes (2) · Anemia, Refractory, with Excess of Blasts (1) · Disease (1) · Febrile Neutropenia (1) · Hodgkin Disease (1) · Leukemia (1) · Leukemia, Myelomonocytic, Juvenile (1) · Lymphoma, Non-Hodgkin (1) · Primary Myelofibrosis (1)
Hematologic Diseases (20) · Hemic and Lymphatic Diseases (20) · Leukemia, Myeloid (20) · Neoplasms (20) · Neoplasms by Histologic Type (20) · Leukemia (19) · Immune System Diseases (7) · Immunoproliferative Disorders (7) · Leukemia, Lymphoid (7) · Lymphatic Diseases (7) · Lymphoproliferative Disorders (7) · Bone Marrow Diseases (5) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Chronic Disease (2)
Cytarabine (3) · Idarubicin (3) · Granulocyte Colony-Stimulating Factor (2) · Peripheral Blood Stem Cell Transplantation (2) · fludarabine (2) · Blood Specimen Collection (1) · Bone Marrow Transplantation (1) · Ceftazidime (1) · Ciprofloxacin (1) · Clofarabine (1) · Drug Therapy (1) · Gemtuzumab (1) · Hematologic Tests (1) · Radioimmunotherapy (1) · Surveys and Questionnaires (1)
PETHEMA Foundation (5) · Assistance Publique - Hôpitaux de Paris (1) · French Innovative Leukemia Organisation (1) · Gadjah Mada University (1) · Goethe University (1) · Great Ormond Street Hospital for Children NHS Foundation Trust (1) · Groupe Hospitalier de la Region de Mulhouse et Sud Alsace (1) · Gruppo Italiano Trapianto di Midollo Osseo (1) · Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (1) · M.D. Anderson Cancer Center (1) · Nantes University Hospital (1) · National Institute of Cancerología (1) · Sheba Medical Center (1) · University Hospital, Bordeaux (1) · University Hospital, Lille (1)
France (6) · Spain (6) · United States (2) · Canada (1) · Germany (1) · Indonesia (1) · Israel (1) · Italy (1) · Mexico (1) · United Kingdom (1)
Sanz Miguel Angel, Dr (2) · Alessandro Rambaldi, MD (1) · Christian Brandts, MD (1) · Diaz Mediavilla Joaquin, Dr (1) · John M Magenau, MD (1) · Norbert Ifrah, MD (1) · Ori Efrati, MD (1) · Patrice Chevallier, MD (1) · Sanz Guillermo, Dr (1) · Shin Mineishi, MD (1) · Stephen J Forman, MD (1)
PMID 15770833, PMID 23317527, PMID 27798515, PMID 29392425, PMID 31554370, PMID 32380535, PMID 38447622